硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 NEFL 抗体对
试剂盒

人 NEFL 抗体对

01AB03522

NEFL encodes the light chain of neurofilaments, which are structural proteins that maintain the caliber of neuronal axons. Mutations in the NEFL gene can lead to Charcot-Marie-Tooth disease types 1F and 2E, which are disorders of the peripheral nervous system characterized by neuropathies.Disturbances in the metabolism and localization of NEFL, as well as mutations in the NEFL gene, have been implicated in the pathogenesis of various neurodegenerative diseases, including Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Huntington's disease. NEFL can be released from damaged neurons and elevated levels of NEFL in the cerebrospinal fluid and blood have been reported as a biomarker for neuronal injury in these conditions. The detection of NEFL has potential applications in disease diagnosis, prognosis, and monitoring of therapeutic treatments.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
NEFL
基因别名
NF68; NFL
蛋白别名
neurofilament light chain; NEFL
UniProt
P07196
物种
Human

产品详情

靶点名称
NEFL
蛋白名称
neurofilament light chain
蛋白别名
Neurofilament light polypeptide; NF-L; 68 kDa neurofilament protein; Neurofilament triplet L protein
靶点基因名
NEFL
基因别名
NF68; NFL
UniProt
P07196
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

NEFL encodes the light chain of neurofilaments, which are structural proteins that maintain the caliber of neuronal axons. Mutations in the NEFL gene can lead to Charcot-Marie-Tooth disease types 1F and 2E, which are disorders of the peripheral nervous system characterized by neuropathies.Disturbances in the metabolism and localization of NEFL, as well as mutations in the NEFL gene, have been implicated in the pathogenesis of various neurodegenerative diseases, including Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Huntington's disease. NEFL can be released from damaged neurons and elevated levels of NEFL in the cerebrospinal fluid and blood have been reported as a biomarker for neuronal injury in these conditions. The detection of NEFL has potential applications in disease diagnosis, prognosis, and monitoring of therapeutic treatments.